Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $76.5 million.

  • Fresenius Medical Care AG's Interest & Investment Income fell 20.44% to -$22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$85.5 million, marking a year-over-year increase of 43.00%. This contributed to the annual value of $76.5 million for FY2024, which is 19.85% down from last year.
  • As of FY2024, Fresenius Medical Care AG's Interest & Investment Income stood at $76.5 million, which was down 19.85% from $95.4 million recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Interest & Investment Income ranged from a high of $95.4 million in FY2023 and a low of $47.9 million during FY2020.
  • For the 3-year period, Fresenius Medical Care AG's Interest & Investment Income averaged around $81.1 million, with its median value being $76.5 million (2024).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 30.58% in 2020, then skyrocketed by 80.74% in 2021.
  • MRY analysis of 5 years shows Fresenius Medical Care AG's Interest & Investment Income stood at $47.9 million in 2020, then soared by 80.74% to $86.6 million in 2021, then dropped by 17.64% to $71.3 million in 2022, then soared by 33.81% to $95.4 million in 2023, then fell by 19.85% to $76.5 million in 2024.
  • Its last three reported values are $76.5 million in FY2024, $95.4 million for FY2023, and $71.3 million during FY2022.